Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
15.32
+0.11 (0.72%)
May 8, 2025, 4:00 PM EDT - Market closed
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Healthcare Realty Trust stock have an average target of 17, with a low estimate of 16 and a high estimate of 19. The average target predicts an increase of 10.97% from the current stock price of 15.32.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock from 5 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 5 | 4 | 2 | 2 | 2 | 3 |
| Sell | 1 | 2 | 2 | 3 | 3 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 4 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Hold Maintains $18 → $16 | Hold | Maintains | $18 → $16 | +4.44% | May 5, 2025 |
| Wells Fargo | Wells Fargo | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | +4.44% | Mar 10, 2025 |
| Scotiabank | Scotiabank | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +10.97% | Feb 25, 2025 |
| Wedbush | Wedbush | Hold → Sell Downgrades $18 → $16 | Hold → Sell | Downgrades | $18 → $16 | +4.44% | Jan 2, 2025 |
| JP Morgan | JP Morgan | Buy → Hold Downgrades $19 | Buy → Hold | Downgrades | $19 | +24.02% | Dec 20, 2024 |
Financial Forecast
Revenue This Year
1.24B
from 1.27B
Decreased by -2.30%
Revenue Next Year
1.27B
from 1.24B
Increased by 2.42%
EPS This Year
-0.34
from -1.81
EPS Next Year
-0.35
from -0.34
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 1.3B | 1.3B | 1.3B | |
| Avg | 1.2B | 1.3B | 1.2B | |
| Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 3.5% | 8.4% | -0.3% | |
| Avg | -2.3% | 2.4% | -2.9% | |
| Low | -10.9% | -7.7% | -8.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.16 | -0.29 | -0.34 |
| Avg | -0.34 | -0.35 | -0.37 |
| Low | -0.47 | -0.42 | -0.39 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.